Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

SAB Biotherapeutics, Inc. Common Stock

SABS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of SABS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
SABS Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
SABS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
SABS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in SABS holdings by institutional investors

Quarterly net insider trading by SABS's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for SABS

4 former government officials from 1 congressional office at 2 lobbying firms have lobbied for SABS, most recently Feb 17, 2022.

  • Alex Pinson House New Schedule C appointee, Dept. of Health and Human Services; Senior Legis. Asst. and Counsel (and other positions), Rep. Hal Rogers; Intern, Rep. Cory Gardner; Intern, Rep. Trey Gowdy Formerly Hal Rogers · DLA PIPER LLP (US) · Feb 17, 2022
  • James Greenwood House New U.S. Representative Formerly U.S. Representative · DLA PIPER LLP (US) · Feb 17, 2022
  • Michael Friedberg House New Staff Director, Rail Subcmte., House Transp. & Infrastructure Cmte.; Professional Staff, House Appropriations Cmte. Formerly Staff Director, Rail Subcmte., House Transp. & Infrastructure Cmte.; Professiona · DLA PIPER LLP (US) · Feb 17, 2022
  • Arlen Specter
    Dan Renberg Senate New Member, Board of Directors, Ex-Im Bank (1999-2003); Leg. Director and Dep. Chief of Staff, Sen. Arlen Specter (1994-1998) Formerly with Arlen Specter · ARENTFOX SCHIFF LLP · Nov 03, 2020

SABS Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

SABS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
SABS Income Statement
SABS Balance Sheet
SABS Cash Flow
U.S. Patents

New SABS patent grants

  • Patent Title: Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses thereof May. 07, 2024
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to SABS from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
SABS News

Recent insights relating to SABS

CNBC Recommendations

Recent picks made for SABS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SABS

SABS Analyst Ratings

SABS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
SABS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $SABS stock a Buy, Sell, or Hold?

  • What is the price target for $SABS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

SABS Top Shareholders
Shareholder
Shares Held
SABS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $SABS stock?

  • Who owns the most shares of $SABS stock?

  • What funds own $SABS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

SABS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view SABS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About SABS

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

  • Address Miami Beach, FL
  • Market Cap 304.8 million
  • Employees 86
  • Industrial Classification Biological Products, (No Diagnostic Substances)

SAB Biotherapeutics, Inc. Common Stock (SABS) Historical Stock Prices

SAB Biotherapeutics, Inc. Common Stock (SABS) closed at $3.35 on September 24, 2026. Over the past year its adjusted close ranged from $1.95 to $4.59. Daily prices go back to January 2, 2014, 2,347 trading days in all.

  • 1 month-12.07%
  • 3 months-13.44%
  • Year to date-10.43%
  • 1 year+55.09%
  • 3 years-36.91%
  • 5 years-66.73%
  • Max+2,133.33%
See every congressional and insider trade on the SABS price chart

Quiver Premium charts SABS's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 3.38 3.44 3.25 3.35 3.35 544,277
Sep 23, 2026 3.49 3.55 3.31 3.39 3.39 406,672
Sep 22, 2026 3.42 3.56 3.42 3.50 3.50 738,965
Sep 21, 2026 3.51 3.55 3.39 3.39 3.39 379,102
Sep 18, 2026 3.49 3.56 3.49 3.51 3.51 1,973,521
Sep 17, 2026 3.43 3.52 3.42 3.50 3.50 374,470
Sep 16, 2026 3.45 3.49 3.35 3.39 3.39 452,388
Sep 15, 2026 3.45 3.51 3.32 3.41 3.41 284,258
Sep 14, 2026 3.42 3.51 3.40 3.46 3.46 237,495
Sep 11, 2026 3.45 3.54 3.38 3.41 3.41 712,045
Sep 10, 2026 3.48 3.53 3.40 3.42 3.42 328,625
Sep 9, 2026 3.61 3.65 3.47 3.48 3.48 200,974
Sep 8, 2026 3.70 3.75 3.62 3.63 3.63 171,264
Sep 4, 2026 3.72 3.75 3.69 3.72 3.72 110,633
Sep 3, 2026 3.76 3.79 3.71 3.72 3.72 161,592
Sep 2, 2026 3.70 3.77 3.60 3.75 3.75 300,420
Sep 1, 2026 3.65 3.75 3.65 3.70 3.70 202,282
Aug 31, 2026 3.76 3.80 3.69 3.71 3.71 201,144
Aug 28, 2026 3.91 3.99 3.79 3.79 3.79 202,596
Aug 27, 2026 3.86 3.93 3.83 3.93 3.93 282,217
Aug 26, 2026 3.80 3.90 3.75 3.88 3.88 274,419
Aug 25, 2026 3.65 3.81 3.61 3.81 3.81 359,374
Aug 24, 2026 3.78 3.78 3.61 3.62 3.62 602,686
Aug 21, 2026 3.74 3.83 3.70 3.78 3.78 195,670
Aug 20, 2026 3.75 3.76 3.66 3.70 3.70 229,627
Aug 19, 2026 3.83 3.88 3.76 3.78 3.78 701,271
Aug 18, 2026 3.75 3.82 3.67 3.79 3.79 351,302
Aug 17, 2026 3.70 3.85 3.69 3.77 3.77 232,027
Aug 14, 2026 3.77 3.78 3.68 3.70 3.70 324,657
Aug 13, 2026 3.82 3.84 3.74 3.75 3.75 256,872
Aug 12, 2026 3.76 3.83 3.70 3.80 3.80 307,681
Aug 11, 2026 3.79 3.79 3.67 3.76 3.76 312,037
Aug 10, 2026 3.89 3.89 3.75 3.78 3.78 297,355
Aug 7, 2026 3.86 3.95 3.85 3.90 3.90 343,907
Aug 6, 2026 3.76 3.87 3.61 3.85 3.85 280,361
Aug 5, 2026 3.86 3.89 3.72 3.77 3.77 284,308
Aug 4, 2026 3.80 3.97 3.73 3.85 3.85 1,162,644
Aug 3, 2026 3.59 3.85 3.50 3.79 3.79 676,234
Jul 31, 2026 3.56 3.58 3.42 3.57 3.57 405,027
Jul 30, 2026 3.49 3.59 3.46 3.56 3.56 208,636
Jul 29, 2026 3.43 3.54 3.40 3.48 3.48 371,503
Jul 28, 2026 3.40 3.49 3.35 3.45 3.45 241,309
Jul 27, 2026 3.53 3.63 3.43 3.44 3.44 609,580
Jul 24, 2026 3.59 3.62 3.47 3.51 3.51 954,269
Jul 23, 2026 3.52 3.66 3.51 3.58 3.58 892,588
Jul 22, 2026 3.63 3.63 3.53 3.58 3.58 180,008
Jul 21, 2026 3.51 3.77 3.51 3.64 3.64 795,134
Jul 20, 2026 3.54 3.62 3.47 3.51 3.51 444,822
Jul 17, 2026 3.58 3.72 3.54 3.54 3.54 678,366
Jul 16, 2026 3.60 3.68 3.50 3.67 3.67 521,435
Jul 15, 2026 3.59 3.67 3.54 3.62 3.62 368,862
Jul 14, 2026 3.76 3.77 3.58 3.60 3.60 318,014
Jul 13, 2026 3.79 3.88 3.70 3.73 3.73 229,955
Jul 10, 2026 3.96 3.96 3.72 3.82 3.82 296,378
Jul 9, 2026 3.78 4.02 3.69 3.96 3.96 634,135
Jul 8, 2026 3.87 3.90 3.72 3.77 3.77 1,064,980
Jul 7, 2026 3.91 3.97 3.54 3.90 3.90 559,769
Jul 6, 2026 3.94 4.07 3.87 3.92 3.92 697,846
Jul 2, 2026 3.91 4.04 3.85 3.92 3.92 266,615
Jul 1, 2026 3.90 3.93 3.81 3.88 3.88 304,532
Jun 30, 2026 3.90 4.01 3.87 3.90 3.90 413,893
Jun 29, 2026 3.80 4.02 3.70 3.90 3.90 606,468
Jun 26, 2026 3.81 3.95 3.68 3.80 3.80 5,650,980
Jun 25, 2026 3.86 3.99 3.85 3.87 3.87 353,591
Jun 24, 2026 4.02 4.04 3.82 3.84 3.84 559,965
Jun 23, 2026 3.83 4.00 3.80 3.87 3.87 395,393
Jun 22, 2026 4.00 4.09 3.90 3.93 3.93 738,943
Jun 18, 2026 3.93 4.10 3.85 4.00 4.00 2,908,294
Jun 17, 2026 3.72 3.89 3.66 3.86 3.86 712,620
Jun 16, 2026 3.91 4.01 3.66 3.66 3.66 1,921,546
Jun 15, 2026 3.51 4.19 3.44 3.90 3.90 5,977,055
Jun 12, 2026 3.40 3.55 3.33 3.33 3.33 356,432
Jun 11, 2026 3.35 3.40 3.30 3.38 3.38 239,803
Jun 10, 2026 3.35 3.45 3.31 3.31 3.31 214,321
Jun 9, 2026 3.40 3.50 3.35 3.36 3.36 362,645
Jun 8, 2026 3.40 3.44 3.33 3.40 3.40 349,037
Jun 5, 2026 3.47 3.47 3.28 3.38 3.38 352,048
Jun 4, 2026 3.35 3.54 3.32 3.47 3.47 304,104
Jun 3, 2026 3.47 3.49 3.32 3.36 3.36 327,018
Jun 2, 2026 3.45 3.54 3.41 3.48 3.48 474,319
Jun 1, 2026 3.74 3.74 3.42 3.44 3.44 529,844
May 29, 2026 3.56 3.65 3.52 3.60 3.60 223,676
May 28, 2026 3.60 3.65 3.55 3.57 3.57 133,800
May 27, 2026 3.80 3.84 3.59 3.60 3.60 283,253
May 26, 2026 3.89 3.92 3.73 3.81 3.81 447,428
May 22, 2026 3.85 3.97 3.84 3.90 3.90 326,176
May 21, 2026 3.65 3.82 3.59 3.81 3.81 373,569
May 20, 2026 3.70 3.85 3.66 3.68 3.68 565,690
May 19, 2026 3.54 3.60 3.40 3.55 3.55 488,016
May 18, 2026 3.68 3.74 3.44 3.56 3.56 772,680
May 15, 2026 3.84 3.88 3.59 3.70 3.70 944,588
May 14, 2026 4.00 4.13 3.78 3.89 3.89 712,920
May 13, 2026 3.62 4.04 3.57 3.96 3.96 757,279
May 12, 2026 3.80 3.81 3.54 3.62 3.62 837,021
May 11, 2026 4.20 4.27 3.67 3.72 3.72 2,627,158
May 8, 2026 4.18 4.59 3.79 4.11 4.11 6,027,640
May 7, 2026 4.10 4.45 3.77 4.09 4.09 3,280,210
May 6, 2026 3.80 3.98 3.63 3.80 3.80 710,945
May 5, 2026 3.66 3.70 3.55 3.68 3.68 363,834
May 4, 2026 3.45 3.79 3.45 3.69 3.69 669,737
May 1, 2026 3.72 3.82 3.46 3.47 3.47 628,636
Apr 30, 2026 3.49 3.84 3.49 3.74 3.74 651,369
Apr 29, 2026 3.51 3.58 3.41 3.48 3.48 322,058
Apr 28, 2026 3.47 3.56 3.43 3.53 3.53 234,317
Apr 27, 2026 3.52 3.65 3.44 3.47 3.47 423,907
Apr 24, 2026 3.71 3.75 3.51 3.52 3.52 555,970
Apr 23, 2026 3.99 4.07 3.79 3.80 3.80 467,590
Apr 22, 2026 3.85 4.01 3.77 3.99 3.99 442,223
Apr 21, 2026 3.87 3.87 3.68 3.81 3.81 413,205
Apr 20, 2026 3.85 3.92 3.73 3.86 3.86 257,390
Apr 17, 2026 3.97 4.03 3.83 3.85 3.85 346,098
Apr 16, 2026 4.02 4.05 3.87 3.92 3.92 308,995
Apr 15, 2026 3.86 4.08 3.80 4.05 4.05 880,895
Apr 14, 2026 3.95 3.98 3.82 3.86 3.86 620,655
Apr 13, 2026 3.92 3.94 3.73 3.90 3.90 268,302
Apr 10, 2026 3.83 3.89 3.73 3.75 3.75 197,594
Apr 9, 2026 3.71 3.85 3.65 3.83 3.83 235,245
Apr 8, 2026 3.83 3.86 3.69 3.73 3.73 201,160
Apr 7, 2026 3.82 3.89 3.71 3.76 3.76 186,120
Apr 6, 2026 3.88 3.90 3.81 3.85 3.85 251,150
Apr 2, 2026 3.89 3.97 3.83 3.88 3.88 205,340
Apr 1, 2026 3.84 3.94 3.84 3.87 3.87 1,320,391
Mar 31, 2026 3.79 3.90 3.78 3.83 3.83 456,589
Mar 30, 2026 3.82 3.86 3.76 3.78 3.78 444,816
Mar 27, 2026 3.79 3.93 3.77 3.85 3.85 808,550
Mar 26, 2026 3.79 3.89 3.79 3.83 3.83 649,813
Mar 25, 2026 3.83 3.94 3.78 3.82 3.82 790,684
Mar 24, 2026 3.99 3.99 3.78 3.87 3.87 627,408
Mar 23, 2026 3.74 3.95 3.74 3.93 3.93 525,623
Mar 20, 2026 3.74 3.84 3.70 3.75 3.75 1,328,280
Mar 19, 2026 3.69 3.95 3.69 3.78 3.78 552,564
Mar 18, 2026 3.97 4.00 3.70 3.70 3.70 3,434,492
Mar 17, 2026 4.01 4.18 3.98 4.07 4.07 334,767
Mar 16, 2026 4.27 4.33 3.93 3.94 3.94 308,214
Mar 13, 2026 4.62 4.72 4.07 4.15 4.15 577,643
Mar 12, 2026 4.87 5.15 4.52 4.59 4.59 2,193,175
Mar 11, 2026 4.26 4.73 4.11 4.58 4.58 2,810,661
Mar 10, 2026 4.05 4.44 4.00 4.10 4.10 2,027,846
Mar 9, 2026 3.71 3.95 3.71 3.84 3.84 175,085
Mar 6, 2026 3.71 3.85 3.64 3.79 3.79 155,952
Mar 5, 2026 3.89 4.11 3.73 3.81 3.81 128,329
Mar 4, 2026 3.93 3.99 3.80 3.93 3.93 109,759
Mar 3, 2026 4.02 4.05 3.76 3.89 3.89 810,807
Mar 2, 2026 3.94 4.18 3.90 4.07 4.07 308,488
Feb 27, 2026 4.08 4.19 4.00 4.10 4.10 402,362
Feb 26, 2026 3.92 4.20 3.86 4.13 4.13 231,886
Feb 25, 2026 3.79 3.96 3.76 3.93 3.93 111,556
Feb 24, 2026 3.66 3.87 3.62 3.74 3.74 582,240
Feb 23, 2026 3.55 3.79 3.54 3.67 3.67 405,788
Feb 20, 2026 3.85 3.85 3.55 3.57 3.57 123,874
Feb 19, 2026 3.76 3.85 3.61 3.79 3.79 193,935
Feb 18, 2026 3.81 3.87 3.64 3.74 3.74 176,606
Feb 17, 2026 3.87 3.89 3.52 3.88 3.88 480,861
Feb 13, 2026 4.15 4.15 3.82 3.85 3.85 274,624
Feb 12, 2026 4.17 4.26 4.06 4.12 4.12 307,376
Feb 11, 2026 4.20 4.30 3.94 4.18 4.18 339,810
Feb 10, 2026 4.21 4.24 4.04 4.18 4.18 250,927
Feb 9, 2026 4.22 4.29 4.04 4.23 4.23 246,182
Feb 6, 2026 3.94 4.28 3.75 4.17 4.17 383,893
Feb 5, 2026 4.20 4.35 3.95 3.98 3.98 290,657
Feb 4, 2026 4.51 4.52 4.20 4.23 4.23 231,551
Feb 3, 2026 4.41 4.60 4.33 4.45 4.45 413,546
Feb 2, 2026 4.41 4.68 4.34 4.38 4.38 522,976
Jan 30, 2026 4.40 4.48 4.27 4.39 4.39 116,997
Jan 29, 2026 4.50 4.53 4.30 4.42 4.42 497,503
Jan 28, 2026 4.50 4.65 4.37 4.41 4.41 709,921
Jan 27, 2026 4.18 4.40 4.11 4.28 4.28 487,135
Jan 26, 2026 4.25 4.27 4.00 4.13 4.13 510,171
Jan 23, 2026 4.00 4.20 3.95 4.04 4.04 488,993
Jan 22, 2026 4.07 4.14 3.93 4.00 4.00 290,148
Jan 21, 2026 4.04 4.21 3.97 4.03 4.03 574,887
Jan 20, 2026 3.82 4.13 3.82 4.01 4.01 527,489
Jan 16, 2026 3.99 4.14 3.92 3.98 3.98 733,647
Jan 15, 2026 4.00 4.00 3.80 4.00 4.00 311,582
Jan 14, 2026 3.93 4.00 3.82 4.00 4.00 779,350
Jan 13, 2026 3.72 4.00 3.68 3.94 3.94 554,141
Jan 12, 2026 3.64 3.79 3.41 3.74 3.74 477,822
Jan 9, 2026 3.87 3.94 3.61 3.68 3.68 411,889
Jan 8, 2026 4.08 4.19 3.78 3.86 3.86 1,023,236
Jan 7, 2026 3.86 4.01 3.65 3.97 3.97 448,800
Jan 6, 2026 3.75 3.78 3.60 3.62 3.62 65,166
Jan 5, 2026 3.74 3.80 3.56 3.74 3.74 107,979
Jan 2, 2026 3.78 3.83 3.70 3.77 3.77 108,294
Dec 31, 2025 3.76 3.80 3.68 3.74 3.74 69,692
Dec 30, 2025 3.60 3.77 3.48 3.77 3.77 212,180
Dec 29, 2025 3.75 3.77 3.60 3.65 3.65 112,055
Dec 26, 2025 3.85 3.87 3.73 3.78 3.78 62,851
Dec 24, 2025 3.86 3.94 3.80 3.84 3.84 55,777
Dec 23, 2025 3.77 4.00 3.77 3.84 3.84 127,415
Dec 22, 2025 3.94 3.96 3.82 3.84 3.84 127,650
Dec 19, 2025 3.99 4.05 3.84 3.99 3.99 824,501
Dec 18, 2025 3.98 4.01 3.88 3.95 3.95 533,289
Dec 17, 2025 3.99 4.03 3.91 3.96 3.96 631,888
Dec 16, 2025 4.01 4.01 3.85 3.99 3.99 521,287
Dec 15, 2025 3.81 4.04 3.75 4.00 4.00 583,668
Dec 12, 2025 3.54 3.89 3.54 3.81 3.81 150,136
Dec 11, 2025 3.66 3.75 3.58 3.59 3.59 112,752
Dec 10, 2025 3.80 3.80 3.51 3.71 3.71 153,049
Dec 9, 2025 3.52 3.86 3.52 3.76 3.76 355,288
Dec 8, 2025 4.00 4.01 3.30 3.55 3.55 448,265
Dec 5, 2025 3.82 4.08 3.81 3.98 3.98 505,899
Dec 4, 2025 3.70 3.92 3.65 3.80 3.80 207,592
Dec 3, 2025 3.66 3.78 3.58 3.70 3.70 260,307
Dec 2, 2025 3.81 3.87 3.61 3.64 3.64 150,129
Dec 1, 2025 3.95 4.03 3.64 3.79 3.79 367,397
Nov 28, 2025 4.08 4.19 3.93 3.95 3.95 232,878
Nov 26, 2025 3.97 4.11 3.90 4.04 4.04 238,275
Nov 25, 2025 4.03 4.15 3.89 3.93 3.93 402,725
Nov 24, 2025 4.00 4.10 3.80 4.02 4.02 165,240
Nov 21, 2025 3.85 4.00 3.68 3.95 3.95 137,698
Nov 20, 2025 3.88 3.97 3.70 3.80 3.80 223,924
Nov 19, 2025 3.90 4.00 3.71 3.83 3.83 224,593
Nov 18, 2025 3.44 3.97 3.42 3.91 3.91 325,762
Nov 17, 2025 3.24 3.50 3.23 3.50 3.50 151,895
Nov 14, 2025 3.03 3.30 3.00 3.24 3.24 268,226
Nov 13, 2025 3.35 3.59 3.08 3.10 3.10 196,086
Nov 12, 2025 3.28 3.44 3.07 3.41 3.41 155,507
Nov 11, 2025 3.15 3.33 3.07 3.27 3.27 86,586
Nov 10, 2025 3.12 3.39 3.10 3.20 3.20 122,558
Nov 7, 2025 2.98 3.20 2.96 3.20 3.20 140,972
Nov 6, 2025 3.15 3.15 2.84 3.10 3.10 376,882
Nov 5, 2025 3.20 3.34 3.13 3.18 3.18 79,526
Nov 4, 2025 3.14 3.33 3.14 3.25 3.25 257,317
Nov 3, 2025 3.25 3.29 3.09 3.25 3.25 207,562
Oct 31, 2025 2.93 3.33 2.93 3.25 3.25 226,573
Oct 30, 2025 3.06 3.08 2.97 3.01 3.01 138,058
Oct 29, 2025 3.03 3.06 2.91 3.04 3.04 128,919
Oct 28, 2025 2.99 3.03 2.90 3.02 3.02 94,433
Oct 27, 2025 2.95 3.19 2.95 3.03 3.03 274,286
Oct 24, 2025 3.00 3.07 2.92 3.03 3.03 201,205
Oct 23, 2025 3.00 3.04 2.81 2.92 2.92 220,992
Oct 22, 2025 2.99 3.02 2.90 3.00 3.00 410,495
Oct 21, 2025 2.94 3.07 2.76 3.00 3.00 514,680
Oct 20, 2025 2.60 3.05 2.57 3.00 3.00 871,584
Oct 17, 2025 2.25 2.54 2.10 2.51 2.51 447,483
Oct 16, 2025 2.31 2.46 2.17 2.17 2.17 144,838
Oct 15, 2025 2.31 2.43 2.27 2.35 2.35 193,553
Oct 14, 2025 2.29 2.32 2.20 2.30 2.30 115,048
Oct 13, 2025 2.32 2.38 2.20 2.31 2.31 112,345
Oct 10, 2025 2.54 2.59 2.27 2.29 2.29 263,681
Oct 9, 2025 2.48 2.60 2.42 2.50 2.50 465,930
Oct 8, 2025 2.35 2.46 2.26 2.34 2.34 280,872
Oct 7, 2025 2.30 2.41 2.23 2.34 2.34 423,950
Oct 6, 2025 2.09 2.49 2.06 2.29 2.29 1,131,856
Oct 3, 2025 1.98 2.08 1.97 2.06 2.06 2,710,059
Oct 2, 2025 1.98 2.04 1.94 2.01 2.01 46,817
Oct 1, 2025 1.99 2.05 1.91 1.98 1.98 64,766
Sep 30, 2025 1.95 2.02 1.85 2.01 2.01 106,550
Sep 29, 2025 2.04 2.10 1.89 1.95 1.95 208,078
Sep 26, 2025 2.06 2.16 1.98 2.01 2.01 199,157
Sep 25, 2025 2.15 2.19 2.03 2.10 2.10 156,804
Sep 24, 2025 2.23 2.35 2.14 2.16 2.16 221,752

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
SAB Biotherapeutics, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at SABS, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation